New formulation comprising a betablocker and optionally a...

Details New formulation comprising a betablocker and optionally a... New formulation comprising a betablocker and optionally a...

A - Human Necessities

61

K

A61K 45/00 (2006.01) A61K 31/138 (2006.01) A61K 31/195 (2006.01) A61K 31/22 (2006.01) A61K 31/366 (2006.01) A61K 31/40 (2006.01) A61K 31/44 (2006.01) A61K 31/505 (2006.01) A61K 45/06 (2006.01) A61P 9/10 (2006.01) A61P 31/06 (2006.01)

Patent

CA 2411100

The present invention relates to pharmaceutical formulations comprising a betablocker, in a maintenance dose lower than 50 mg, particularly in the range of 25 to 47 mg, optionally containing a cholesterol lowering agent, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, as well as a method of treatment and use of the formulations for the treatment of atherosclerosis and related diseases.

Cette invention se rapporte à des formulations pharmaceutiques comprenant un bêtabloquant, dans une dose d'entretien inférieure à 50 mg, comprise plus particulièrement entre 25 et 47 mg, contenant éventuellement un agent hypocholestérolémiant, mélangé à un adjuvant, un diluant ou un excipient pharmaceutiquement acceptable, ainsi qu'à un procédé de traitement et d'utilisation de ces formulations dans le traitement de l'athérosclérose et des troubles apparentés.

Affiliated with

Also associated with

Rating

New formulation comprising a betablocker and optionally a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New formulation comprising a betablocker and optionally a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New formulation comprising a betablocker and optionally a... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1794650